DK175482B1 - Human vævsplasminogenaktivator-variant - Google Patents

Human vævsplasminogenaktivator-variant Download PDF

Info

Publication number
DK175482B1
DK175482B1 DK199001122A DK112290A DK175482B1 DK 175482 B1 DK175482 B1 DK 175482B1 DK 199001122 A DK199001122 A DK 199001122A DK 112290 A DK112290 A DK 112290A DK 175482 B1 DK175482 B1 DK 175482B1
Authority
DK
Denmark
Prior art keywords
human tissue
plasminogen activator
type plasminogen
amino acid
tissue type
Prior art date
Application number
DK199001122A
Other languages
Danish (da)
English (en)
Other versions
DK112290A (da
DK112290D0 (da
Inventor
Adair J Hotchkiss
John V O'conner
Michael W Spellman
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DK112290D0 publication Critical patent/DK112290D0/da
Publication of DK112290A publication Critical patent/DK112290A/da
Application granted granted Critical
Publication of DK175482B1 publication Critical patent/DK175482B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK199001122A 1987-11-06 1990-05-04 Human vævsplasminogenaktivator-variant DK175482B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11809887A 1987-11-06 1987-11-06
US11809887 1987-11-06
PCT/US1988/003901 WO1989004368A1 (fr) 1987-11-06 1988-11-02 Nouvelle variante d'activateurs de plasminogene de tissus humains
US8803901 1988-11-02

Publications (3)

Publication Number Publication Date
DK112290D0 DK112290D0 (da) 1990-05-04
DK112290A DK112290A (da) 1990-07-06
DK175482B1 true DK175482B1 (da) 2004-11-08

Family

ID=22376492

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199001122A DK175482B1 (da) 1987-11-06 1990-05-04 Human vævsplasminogenaktivator-variant

Country Status (18)

Country Link
EP (2) EP0387290B1 (fr)
JP (1) JPH03500843A (fr)
KR (1) KR920009521B1 (fr)
AT (1) ATE151812T1 (fr)
AU (2) AU2804989A (fr)
CA (1) CA1341609C (fr)
DD (1) DD286613A5 (fr)
DE (1) DE3855874T2 (fr)
DK (1) DK175482B1 (fr)
FI (1) FI102970B1 (fr)
HU (1) HU215230B (fr)
IL (1) IL88247A0 (fr)
NO (1) NO307612B1 (fr)
NZ (1) NZ226829A (fr)
PH (1) PH30064A (fr)
PT (1) PT88938B (fr)
WO (1) WO1989004368A1 (fr)
ZA (1) ZA888250B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5246850A (en) * 1990-07-31 1993-09-21 Genentech, Inc. DNA molecules encoding human tissue plasminogen activator variants with decreased clearance, vectors, and host cells
CA2086835C (fr) * 1990-07-31 2002-04-02 Bruce A. Keyt Variants d'activateur tissulaire du plasminogene a clairance reduite
US5242688A (en) * 1990-12-24 1993-09-07 Eli Lilly And Company Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants
DK0643772T3 (da) 1992-06-03 1998-02-02 Genentech Inc Glycosyleringsvarianter af vævsplasminogenaktivator med forbedrede terapeutiske egenskaber
DK0827751T3 (da) * 1996-09-06 2003-03-31 Chemo Sero Therapeut Res Inst Medicinsk præparat indeholdende vævsplasminogenaktivator og nicotinamid
US7084118B2 (en) 2002-02-22 2006-08-01 Genentech, Inc. Combination treatment with t-PA variant and low molecular weight heparin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984001786A1 (fr) * 1982-10-28 1984-05-10 Beecham Group Plc Derives d'enzymes et leur utilisation dans le traitement de la thrombose
EP0293394B2 (fr) * 1986-01-31 2003-10-29 Genetics Institute, LLC Nouvelles proteines thrombolytiques
IE81073B1 (en) * 1986-03-18 2000-01-12 Genentech Inc Modified human tissue-type plasminogen activator and its preparation
IL87276A (en) * 1987-08-03 1995-07-31 Fujisawa Pharmaceutical Co Analog of a tissue plasminogen activator containing the Pringle 2 and protease regions only, DNA encoding it, processes for its preparation, and pharmaceutical preparations containing it
ZA887556B (en) * 1987-10-09 1989-07-26 Monsanto Co Modified tissue plasminogen activator

Also Published As

Publication number Publication date
FI902239A0 (fi) 1990-05-04
HU890157D0 (en) 1990-12-28
DK112290A (da) 1990-07-06
PT88938B (pt) 1993-05-31
NO901995D0 (no) 1990-05-04
AU2804989A (en) 1989-06-01
DK112290D0 (da) 1990-05-04
AU2131792A (en) 1992-11-19
EP0387290B1 (fr) 1997-04-16
FI102970B (fi) 1999-03-31
NO901995L (no) 1990-07-05
ZA888250B (en) 1990-07-25
CA1341609C (fr) 2011-02-01
KR920009521B1 (ko) 1992-10-17
NO307612B1 (no) 2000-05-02
EP0754753A1 (fr) 1997-01-22
HU215230B (hu) 2000-03-28
DE3855874D1 (de) 1997-05-22
NZ226829A (en) 1991-06-25
KR890701733A (ko) 1989-12-21
FI102970B1 (fi) 1999-03-31
DD286613A5 (de) 1991-01-31
JPH03500843A (ja) 1991-02-28
ATE151812T1 (de) 1997-05-15
EP0387290A1 (fr) 1990-09-19
AU658909B2 (en) 1995-05-04
IL88247A0 (en) 1989-06-30
PH30064A (en) 1996-11-08
PT88938A (pt) 1989-11-30
WO1989004368A1 (fr) 1989-05-18
HUT54209A (en) 1991-01-28
DE3855874T2 (de) 1997-09-11

Similar Documents

Publication Publication Date Title
DK175490B1 (da) Human-vævstype-plasminogenaktivator-polypeptider og fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende disse
DK175380B1 (da) Mutant af human vævsplasminogenaktivator, DNA-sekvens som koder herfor, replicerbar udtrykkelsesvektor til at udtrykke denne DNA-sekvens, mikroorganisme transformeret med denne vektor, cellekulturer transformeret med denne....
US4766075A (en) Human tissue plasminogen activator
FI88932B (fi) Framstaellning av funktionellt maenskligt urokinasprotein
EP0093619A1 (fr) Plasminogène-activateur de tissu humain, compositions pharmaceutiques le contenant, procédés pour sa préparation ainsi que ADN et intermédiaires cellulaires transformés pour la mise en oeuvre de ces procédés
US5763253A (en) Methods of preparing tissue plasiminogen activator derivative composition
US4853330A (en) Human tissue plasminogen activator
US6274335B1 (en) Method of treatment using recombinant human tissue plasminogen activator
DK175482B1 (da) Human vævsplasminogenaktivator-variant
EP0297066B1 (fr) Nouvelles enzymes fibrinolytiques
US5185259A (en) Truncated human tissue plasminogen activator
EP0275606A1 (fr) Activateurs hybrides du plasminogène avec des propriétés thrombolytiques et médicaments contenant ces activateurs du plasminogène
PT93439A (pt) Processo para a preparacao de mutantes do activador de plasminigenio urinario
US5589361A (en) Human tissue-type plasminogen activator variant
EP0336508A1 (fr) Mutant recombinant d'une urokinase du type activateur du plasminogène constitué d'une seule chaîne et produite par une mutagénèse remplaçant la lysine 158 par de l'histidine
IL104953A (en) Method for producing tissue-type plasminogen activator by transforming and cultivating a host cell incapable of forming complex glycoproteins
US6682733B1 (en) Fibrinolytic enzymes
BG60507B2 (bg) Човешки тъканен плазминогенен активатор
EP0535037A1 (fr) Activateurs de plasminogene hybrides

Legal Events

Date Code Title Description
PUP Patent expired